Skip to main content

Now live! Explore the program for the upcoming 2024 Global Conference, taking place May 5-8, 2024.

Session Listing

June 22-23, 2021

Future of Health Summit

Convening the world’s leading minds to confront and work towards solving the most significant health challenges.
Select All | None
Tuesday, June 22, 2021
Wednesday, June 23, 2021

Work Out with Dogpound
8:00 AM - 8:45 AM EDT

This 45-minute virtual workout led by Dogpound's elite trainer, Richy Castro, will address full body conditioning movements designed to improve performance, enhance mobility, and build strength. You'll leave each of Dogpound's daily sessions feeling strong, energized, and balanced within body and mind. This is an interactive session (not a webinar). You are welcome to turn your camera on to engage with Dogpound's trainers or leave it off if you prefer.

By selecting and joining this session, you agree to Dogpound's Customer Liability Waiver, Release, and Indemnity Agreement which can be viewed below.

This session is for Future of Health Summit registrants only.

Dogpound Release of Liability

Around the world, numbers of type 1 diabetes (T1D) cases are rising. It's expected that by 2050, 5 million people in the United States alone will have been diagnosed. T1D can be diagnosed at any age, even in infancy, and is a treatable—but not curable—condition. With patients and their families encumbered by financial burdens, lifestyle changes, and psychosocial repercussions, the development of new therapies for T1D is imperative This is a pivotal time for T1D research, with new treatment technologies, such as the artificial pancreas, and promising discoveries in the prevention and cure space. This discussion will highlight the perspectives of various stakeholders who are working together to help people affected by T1D. Panelists will share their enthusiasm over new treatments and innovations, and will assess the resources needed to overcome current challenges in T1D investigation.

Over the last 18 months, few sectors have been so challenged and had to adapt more quickly than health-care delivery and epidemiology. As the pandemic took over, hospitals were flooded to over-capacity with patients requiring special treatment protocols, while staffs scrambled to adopt heighted safety procedures overnight. Public health officials had to track the outbreak and issue safety directives while working with imperfect data. As the vaccines continue to roll out, there is not only hope of a return to normal but an opportunity to use the clinical and data-driven insights gained during the pandemic to improve health-care delivery and anticipate community health needs. Join us for a discussion of the trends shaping health care in the years to come.

COVID-19 has taken a tremendous toll on the mental health of people across the globe, with changes simultaneously to home life and the work environment, and sustained stress affecting millions of workers. Employers have the power to impact individual employees, families, and communities by seeing the "whole person," engaging, and committing to mental and physical health. By understanding the challenges employees face, organizations can not only mitigate the long-term negative mental-health effects of this crisis, including the heightened risk for substance use that can lead to addiction, but retain the talent they've worked hard to attract. While many agree on the need for updates to policies and greater access to mental-health resources, the commitment needed to drive change, transform, and prioritize such revisions often stems from the personal or lived experience of someone in a leadership position.

COVID-19 and the Future of Aging
10:30 AM - 11:30 AM EDT

The COVID-19 pandemic has revealed health, social, and racial divides, and exposed negative perceptions of the value of older adults and their roles in a multi-generational society. Concurrently, it is also accelerating and changing broad trends in work, retirement, and health. The time is ripe for a critical examination of the long-term impacts of the COVID-19 pandemic on older adults, including what can be done to stem the worst outcomes and to realize silver linings. During this panel, experts across sectors will share their perspectives on how we can forge a better future in the wake of the pandemic.

Competition has always been part of science and can have positive effects. However, hyper-competition for the resources and positions needed to conduct science suppresses the creativity, cooperation, risk-taking, and original thinking required to make discoveries.  If funders took a different approach, prioritizing collaborative behavior such as data sharing and open access publications, would science move faster? COVID-19 showed the world what's possible when scientists collaborate: Accelerated vaccine development, lives saved, and a hope that real system change in medical research is within reach. The speakers in this session will tell a story of cooperation and collaboration. They will show how lessons learned from COVID-19 can be applied to create better research systems.

In partnership with the Wellcome Trust, the Milken Institute's FasterCures and Financial Innovations Lab are examining ways to leverage innovative finance solutions to support the development and commercialization of new antibiotics. Government and philanthropy have led the way in funding important early-stage research in antibiotics, but their leadership alone will not be enough to create a sustainable and resilient antibiotics market. During this session, we will discuss the potential for specific innovative financing approaches to drive investment in the antibiotics market and the steps that need to be taken to implement them.

Independent restaurants are the backbone of local economies and the heartbeat of communities. An estimated 110,000 restaurants in the US have closed over the past year, with more than three million jobs vanishing from pre-pandemic levels. The impact of COVID-induced closures has been felt across America, affecting suppliers, farmers, and families in addition to restaurant workers—with disproportionate impacts upon people of color, women, and immigrants. With the recent passing of the Restaurant Revitalization Fund, and as society begins to reopen, how can food restore our shared culture and bring people together once again? How can we rebuild the health of our communities alongside the health of our economy?

As a result of the COVID-19 pandemic, systemic health-care inequities persist along with public skepticism and mistrust in the system. Medical researchers and providers, policy makers, and business leaders can highlight the importance of ROI by establishing ways to draw on the expertise of nontraditional community stakeholders. A focus on ROI—a "win-win" for both patients and biomedical industry—can help build trust among deeply skeptical groups. What is industry's role in addressing health equity while building value based on the expertise of underrepresented groups? Panelists propose actionable solutions and best practices for integrating ROI, aligning incentives, and widening access to vital therapies while enlisting patients and communities in building an equitable biomedical research ecosystem. A further focus is the role of business and finance in prioritizing community investment and value to achieve health equity.

Although the rapid development of COVID-19 vaccines has been an extraordinary success, the international distribution of, and access to, vaccines has been uneven at best. Many countries do not yet have sufficient quantities of the vaccines, raising many important scientific, policy, and moral questions. How vaccines are distributed globally will not only impact the long-term duration and subsequent waves of this virus, but will also inform the pace at which the world economy recovers from the COVID-induced downturn. This panel will discuss some of the challenges inherent in coordinating the global response, as well as the innovative strategies employed to ensure that vaccine distribution is not only equitable, but also contributes positively to both global recovery and local resiliency.

The coronavirus pandemic laid bare the stark vulnerabilities of the US long-term care (LTC) system, but also unleashed a rapid acceleration in the adoption of tech-enabled care for older adults living at home and in residential facilities. Through continued expansion and extension of telehealth, an estimated $250 billion in health care services could be virtualized—a massive shift in the way care is delivered. Technology-driven solutions have the potential to enhance quality, reduce costs, and increase access across the entire health system. Recognizing the growing need for LTC, the emergence of home-based and alternative care delivery models, and the rapid evolution of technology, this panel will spotlight opportunities for innovation to promote integrated health and home care.

Several proposals to lower drug costs have been introduced in recent years in response to growing public concern about drug prices and affordability. A key element included in recent proposals would tie the prices of certain medicines to the prices paid in other countries. As discussions on these policies continue, it is important to consider how these proposals may affect research and development decisions and capital investments in the sector. In this session, experts will discuss how policymakers can address patients' concerns about drug prices while sustaining robust investment in drug development.

Philanthropy Leadership Collective: Biomedical Affinity Group (Invite only)
1:30 PM - 2:30 PM EDT

The Milken Institute's Food Is Medicine (FIM) Task Force aims to accelerate action in FIM by serving as a hub where industry leaders in health care, insurance, and food retail ventures can share information while learning from other organizations and leaders in the field. During this private meeting, the task force members will review emerging policy ideas and engage in collaborative discussion on access to healthful food and food as medicine to identify opportunities and build consensus on actions indicated on FIM.

Mark Twain famously said that our two most important days in life are the day we are born, and the day we find out why. But Light Watkins would add a third day to that philosophy: the day we start taking action on our "why." Some people spend years contemplating their passion and purpose without ever taking meaningful action, due to a fear of failure, embarrassment, or perhaps self-imposed racism, ageism, or sexism. But we could make the argument that, out of our three important days, our third day is the most important. And the best news of all is that our third day can be today. In his presentation, Light Watkins will give the participants a crash course in identifying their true purpose, and suggest initial steps for taking meaningful action. After all, a mindful life is one of purpose.

According to the Center for Disaster Philanthropy, philanthropists from around the world responded to COVID at levels that were orders of magnitude higher than any other human crisis. To mitigate the next pandemic, which, experts say, is bound to happen, it is crucial to evaluate philanthropy's response to this one. What lessons can be extrapolated and used to respond to future pandemics? What infrastructural gaps were exposed that philanthropy is best positioned to fill? Experts will discuss the evolving role of philanthropic funding during the COVID-19 pandemic and explore how collaborative, strategic investments can better prepare us for future crises.

How did you use your time to cope during the COVID-19 pandemic? Did you write a book? Paint a picture? Or bake sourdough? Maybe you perfected your downward dog? Or practiced daily meditation? During the pandemic, people were obliged to remain indoors as far as possible, physically separated from loved ones, colleagues, and communities. This time of turning inward offered the space and opportunity to dig deeper inside ourselves—to stay grounded while sparking our creative interests. Leaders across the fields of faith, mindfulness, art, and psychology will discuss the implications and opportunities, as we emerge from isolation and separation, to reconnect with our families and friends to break bread, enjoy shared activities, and convene—safely.

Over the past quarter century, the Milken Institute's FasterCures center has played a central role in accelerating medical solutions. It has created a new culture in the medical research community based on collaboration, patient activism, translational science and a sense of urgency. Institute Chairman Michael Milken moderates this panel of four executives who have led FasterCures and its predecessor organizations. As the world emerges from the COVID-19 pandemic, their optimism provides abundant hope for continued progress against all life-threatening diseases.

With a tumultuous 2020 in the rearview mirror, CEOs continue to transition from crisis management to forward planning, as companies and industries prepare for an economic reopening and welcoming employees back to the office. This off-the-record discussion with leading health CEOs and Institute Chairman Michael Milken will draw on the lessons learned from the past year and the challenges that lie ahead. CEOs of companies across the health ecosystem will share best practices during and coming out of the pandemic, along with their experiences navigating barriers and maximizing organizational performance during a time where the world is reliant on accelerated outputs.

Adults in the US fear Alzheimer's disease more than cancer, stroke, and heart disease combined. Today, more than 6 million Americans have Alzheimer's and related dementias, and that number is projected to double in coming years. Unfortunately, stigma associated with Alzheimer's disease often prevents people from seeking a cognitive assessment when symptoms arise. Similarly, stigma raises barriers that block physicians and patients from communicating openly about memory concerns. This panel will discuss the results of an AARP national survey of consumers and health-care providers examining the stigma surrounding dementia. The discussion will highlight why early detection of dementia can help alleviate fear, discuss ways to reduce risk, and chart a way forward to increase diagnosis and improve care.

Many COVID-19 survivors of all ages experience alarming neurological and physical signs and symptoms post-infection. Dementia-like symptoms, including memory loss and confusion—described as "brain fog"—are lingering burdens for some, while others confront an array of physical symptoms including shortness of breath, cough, and chronic fatigue. Several studies are in progress to investigate the impact of COVID-19, including a possibly increased risk of later-life cognitive decline or dementia. Researchers, clinicians, and health policy makers are striving to understand COVID-19's long-term impact as well as the supports needed by survivors and their families.

Employers are uniquely positioned to transform the intersection of workplace and public health crises, including mental health and addiction. Nearly 50 percent of Americans receive health benefits through their employers. Topics of high interest include access to good-quality care, both physical and mental; health economics; and investing in health-tech innovation. Also urgent are transformation of workplace culture, stigma, awareness, and prevention. The impact of fraud on quality of care is a perennial concern, while organizational performance, barrier removal, and talent retention are timely issues. Addressing these priorities may seem costly, but prevention, risk management, and upstream intervention will help build more resilient communities and cost less than the failure to promote a lasting, scalable response in the workplace. This invite-only session previews the joint approach of the Milken Institute and the Leidos CEO Pledge Collaborative Action Group in advance of the October kick-off. A leaders' panel will precede a group discussion.

The COVID-19 pandemic has proved that global cooperation and public-private partnerships can successfully strive together in times of crisis to make a tangible impact. Inspired by these collaborative efforts, this panel will explore how uniting to defeat a common enemy, cancer, might shape the future of cancer treatment and care. Despite tremendous innovation in oncology care in recent years, with breakthroughs in diagnosis and treatment driving increases in survival for many forms of cancer, it is still one of the leading causes of death worldwide. How might cooperation across borders, public-private partnerships, and insights from the patient community, regulators, and non-government organizations spur research and technological innovation in cancer treatment? How could global collaboration catalyze the development of new therapies as well as the biological understanding of cancer?

The COVID-19 pandemic highlighted the importance of healthy diets and a resilient food system. Leaders across the food industry have transformed their organizations to meet urgent and evolving needs. Participants in this panel are industry leaders who will discuss the transformation of their businesses and reveal their visions for the future of a healthy, equitable, and sustainable food system.

Work Out with Dogpound
8:00 AM - 8:45 AM EDT

This 45-minute virtual workout led by Dogpound's elite trainer, Rebekah Santiago, will address full body conditioning movements designed to improve performance, enhance mobility, and build strength. You'll leave each of Dogpound's daily sessions feeling strong, energized, and balanced within body and mind. This is an interactive session (not a webinar). You are welcome to turn your camera on to engage with Dogpound's trainers or leave it off if you prefer.

By selecting and joining this session, you agree to Dogpound's Customer Liability Waiver, Release, and Indemnity Agreement which can be viewed below.

This session is for Future of Health Summit registrants only.

Dogpound Release of Liability

The COVID-19 pandemic has thrown into stark relief the gaps in the global ability to quickly identify, track, and combat the emergence of pathogenic threats. Such menaces include formerly unknown viruses of epidemic potential as well as the development of antibiotic resistance that threatens medical practice. As we fight the current pandemic and struggle to identify best ways to reopen communities worldwide, the need for a coordinated, active early warning system is more acute than ever. Now is the time to unite the global health community in mobilizing such a network. Leaders at the forefront of addressing this pandemic and preventing another will discuss what it will take to build an active, coordinated, and sustainable early warning system to detect and combat future threats.

The great disparities in public health outcomes due to race, class, and location have been brought center stage as a result of the Covid-19 pandemic. We are now more aware than ever of the importance of the social determinants of health—an individual's social and economic conditions including housing status, job security, and social mobility—as structural drivers of health equity. Too many of the efforts designed to address these inequities have been siloed, underfunded, or lack enforcement. How do we move past buzzword-filled conversations to merge a cohesive policy agenda with actionable solutions that have health equity at their core? How do we fund these efforts and evaluate success? Panelists will provide multiple perspectives on implementing more effective public health policies, examining the important roles played by poverty, racial disparities, and social inequality in effecting outcomes.

How Should We Value a Cure?
10:30 AM - 11:30 AM EDT

In the landscape of new, potentially curative cell and gene therapies, many uncertainties remain including how to pay for them. Value assessment approaches have been looked to as a way to achieve higher-value healthcare and many efforts are aimed at centering the patient perspective. Although we've come a long way, much work remains to be done to ensure that determinations of the value of cell and gene therapies integrate the perspectives of those they are intended to help: Patients. In this session, experts will discuss the progress that has been made in recent years as well as remaining gaps and challenges that we should urgently work to address.

Access to nutritious foods is essential to promoting health and preventing disease. Although malnutrition can affect anyone, children, older adults, and people with chronic diseases are especially at risk of "hidden hunger." Healthy diets are a critical component in addressing chronic diseases including obesity, diabetes, and heart disease. A childhood diet lacking the necessary vitamins and minerals, despite adequate calories, can cause irreversible damage that has educational, financial, and long-term health consequences reaching far into adulthood. The multifaceted and complex racial and ethnic disparities in the United States have exacerbated food and nutrition insecurity among vulnerable populations and need to be prioritized by the health-care system. As the world prepares for a new normal beyond the pandemic, we must prioritize nutrition to promote health and prevent and treat disease.

The Center for the Future of Aging Advisory Board is comprised of the Leadership Council and the Academic and Policy Council, leaders and experts working to ensure that individuals, institutions, and societies are prepared for the realities of population aging. The Center's invitation-only June Advisory Board meeting will open with a conversation with Bob Casey, US Senator, Pennsylvania, and Chairman, Senate Special Committee on Aging, followed by program updates and collaborative discussion on critical issues spanning healthy longevity and financial wellness. Together, the Center's Advisory Board and staff work to identify opportunities, build consensus on action, and inform the Center's plans and programs for the year ahead.

This session will begin with a conversation with American Cancer Society CEO, Karen Knudsen followed by a panel discussion.

Researchers have made significant progress in treating cancers, with a range of new interventions providing important options for patients. However, for myriad reasons, much of the innovation to date is indicated to treat patients with advanced disease. Today, screening tests are widely available for only five cancer types. For many patients, cancer is diagnosed when they present with symptoms, with the result that treatment is initiated only after the disease has already progressed. A new wave of multi-cancer early detection (MCED) tests has the potential to identify cancers earlier, opening doors to research and treatment opportunities for cancers at earlier stages than before. Learn more about how earlier detection has the potential to shift the research paradigm and drive new advances in cancer treatment.

Part 1:

  • Guest Karen Knudsen, CEO, American Cancer Society
  • Moderator Michael Milken, Chairman, Milken Institute

Part 2:

  • Moderator Jody Hoyos, President and Chief Operating Officer, Prevent Cancer Foundation
  • Speaker Jeff Allen, President and CEO, Friends of Cancer Research
  • Speaker Camille Hertzka, Vice President, Head of Medical Affairs, US Oncology, AstraZeneca
  • Speaker Josh Ofman, Chief Medical Officer and External Affairs, GRAIL
  • Speaker Azra Raza, Professor of Medicine and Director, Myelodysplastic Syndrome Center, Columbia University


This session will begin with a conversation with US Representative, California, Anna Eshoo followed by a panel discussion.

During the pandemic, the increased use of virtual care has been an important tool to ensure that patients stay in communication with their health-care providers. However, with fewer in-person visits, the impact of COVID-19 on people living with chronic diseases may be greater than we realize. Efforts to flatten the curve have resulted in deferring care for non-COVID patients. This is raising concerns that medical conditions that might normally have been caught will go undetected, adding to the psychosocial and economic cost for patients, the health-care system, and society. How can we build on the remarkable innovations developed in response to the pandemic to address the chronic non-COVID conditions that millions of people continue to live with? Should we expect an influx of patients seeking screenings, diagnoses, and treatments once the pandemic recedes? Have we effectively addressed the needs of patients outside of COVID-19?

Part 1:

  • Guest Anna Eshoo, US Representative, California; Chair, Energy and Commerce Subcommittee on Health, US House of Representatives
  • Moderator Esther Krofah, Executive Director, FasterCures, Milken Institute

Part 2:

  • Moderator Lynn Goldman, Michael and Lori Milken Dean of Public Health, Milken Institute School of Public Health, The George Washington University
  • Speaker Mike Gladstone, Global President, Inflammation and Immunology, Pfizer
  • Speaker Caren Heller, Chief Scientific Officer, Crohn's & Colitis Foundation of America
  • Speaker Shantanu Nundy, Chief Medical Officer, Accolade; Primary Care Physician; Author, "Care After Covid: What the Pandemic Revealed is Broken in Healthcare and How to Reinvent It"
  • Speaker Gary Puckrein, President and CEO, National Minority Quality Forum

Take a break from your day for a series of movements that imbed Tai Chi, Chi gong, and modern dance into a process that incorporates the domains of integration into one symbolic movement.

Mental health research and models of care have been criticized for excluding groups disproportionately burdened by mental health challenges. The convergence of youth movements, equity movements, and new awareness of mental health challenges brought on by the COVID-19 pandemic is changing the landscape. Organizations focused on mental health and well-being are driving new models of engagement by empowering once-sidelined communities: youth, BIPOC, and those living with serious mental health disorders. These changes have the power to create more inclusive systems of research and care accessible to all. Further, philanthropy can help usher in a new era within mental health care by amplifying different voices, including those of lived experiences. Panelists will discuss how the mental health landscape is becoming more inclusive. They will explore diverse perspectives and experiences that can be harnessed to ensure that mental health support reaches those who need it.

This session will begin with a conversation with White House National Climate Advisor, Gina McCarthy followed by a panel discussion.

The linkage between climate change and human health is increasingly evident, as frequent climate disruptions impact a range of issues such as air pollution, the distribution of food, and the spread of infectious disease. Community NGOs are leading the way, developing partnerships with private, civic, and corporate sectors to advance equitable access to clean water, energy, and food systems, and build healthier communities. Panelists will explore how we can improve health outcomes, treat disease, and—through climate-smart solutions—drive equitable development while preventing a climate disaster.

Part 1:

  • Guest Gina McCarthy, White House National Climate Advisor
  • Moderator Anne Thompson, Correspondent, NBC News

Part 2:

  • Moderator Anne Thompson, Correspondent, NBC News
  • Speaker Robert Blaine, Senior Executive and Director, Institute for Youth, Education, and Families, National League of Cities
  • Speaker Michael Goldstein, Donald P. Babson Chair in Applied Investments, Professor of Finance, Babson College
  • Speaker Ailun Yang, Head of International Programs, Climate and Environment, Bloomberg Philanthropies


Advances in public health and bioscience have added decades to average lifespans over the past century. But the way we plan has not met the moment. As evidence builds about the connections between healthy longevity and work, purpose, learning, and financial security, it is increasingly clear that traditional retirement must be reimagined. How should it change to ensure that older adults can realize the upsides and mitigate the risks? How should future retirees prepare? A panel of multi-sectoral experts will discuss the future of retirement and opportunities to advance policies, practices, equity, and cultural norms to support longer, healthier, and more meaningful lives.

The COVID-19 pandemic tested US and global supply chains by requiring the production and distribution of hundreds of millions of units of key medical products at unprecedented speed. In contrast to earlier crises, when local shortages could be solved by shifting products from unaffected markets, the pandemic caused a worldwide spike in demand that removed the slack from supply chains, creating new logistical challenges.

Ultimately, the supply chain proved resilient enough to deliver essential supplies on an unprecedented scale. However, the crisis shed light on vulnerabilities in national preparedness and the need for greater coordination and collaboration.

As we emerge from this crisis, the supply chain is applying lessons learned and best practices to prepare for the next one. How can the public and private sector work together to make sure the United States is ready for the next public health crisis?

The COVID-19 pandemic has led to an unprecedented acceleration in many areas of scientific research and development. It has not only enabled an extraordinarily rapid vaccine rollout but has given health-care companies a chance to showcase the benefits of their groundbreaking work—from gene sequencing and DNA printing to big data solutions. How can we take advantage of this momentum and apply new scientific findings to push the boundaries of public health? Join our chairman Michael Milken and some of our most innovative healthcare leaders as they discuss the era of the genome and data-driven medicine and the opportunities it offers to improve the long-term quality of our lives.

Mothers have borne the brunt of the COVID-19 pandemic, juggling paid and unpaid work, continuing to raise children, and providing care for family members—all while grappling with an unprecedented health crisis. Economic and social stressors of the pandemic have made a significant impact on maternal health and well-being, and this stress is magnified by numerous intersecting issues, including race and poverty, educational inequity, and loss of childcare services. Nearly three million women dropped out of the workforce over the last year, roughly one third of them mothers, with Black, Hispanic, and single mothers disproportionately affected. What will the global return to the workplace look like for mothers? And what will the pandemic's lasting impacts be for mothers and children alike?

This session will begin with a conversation with Ranking Member, Energy and Commerce Committee, US House of Representatives, Cathy McMorris Rodgers followed by a panel discussion.

During the pandemic, in the face of cascading health and social crises, health and science leaders illuminated the path forward. Massive scientific investments led to groundbreaking advancements in vaccination and therapy. Unprecedented collaboration in the public and private sectors enabled remarkable progress across industries. Telehealth and digital tools proved the potential of technologies to respond to health challenges. But the pandemic revealed a darker side as well. Wide gaps and disparities in healthcare delivery, quality, and access led to tragic outcomes as underserved communities and under-resourced countries struggled in the pandemic's grip. Will we heed the lessons of COVID-19? To build on the successes and combat the failures, solutions will require innovation and commitment from across the health ecosystem. Our panel of experts will discuss the possibilities.

 Part 1:

  • Guest Cathy McMorris Rodgers, US Representative, Washington; Ranking Member, Energy and Commerce Committee, US House of Representatives
  • Moderator Mary Ellen McIntire, Staff Reporter, Roll Call

 Part 2:

  • Moderator Sam Baker, Health Editor, Axios
  • Speaker Amy Abernethy, former Principal Deputy Commissioner, US Food and Drug Administration
  • Speaker Kelvin Baggett, Executive Vice President and Chief Impact Officer, McKesson
  • Speaker Tanisha Carino, Executive Vice President and Chief Corporate Affairs Officer, Alexion Pharmaceuticals
  • Speaker Gary Michelson, Founder and Co-Chair, Michelson Medical Research Foundation
  • Speaker Andrew Plump, President, Research and Development, Takeda Pharmaceuticals